RANI
RANI
NASDAQ · Pharmaceuticals

Rani Therapeutics Holdings-A

Penny Stocks Pharmaceutical Stocks Healthcare Stocks
$1.06
-0.08 (-7.02%)
As of Mar 24, 10:09 PM ET ·
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 8 89%
Hold 1 11%
Sell 0 0%
Price Target
Analyst Price Target +3,404.7% upside
Low Target $30.65
Average Target $37.15
High Target $44.71
Current Price $1.06
Current
$1.06
Target
$37.15
$30.65 $37.15 avg $44.71
Scenario Analysis
Bear Case
$30.65
2,791.5%
Low target
Base Case
$37.15
+3,404.7%
Avg target
Bull Case
$44.71
+4,117.9%
High target
Risk/Reward
1.5x
Balanced
Price in Context
52-Week High
$3.87
-72.6% from high
52-Week Low
$0.39
+173.9% from low
Target vs 52W High
$37.15
+859.9% vs high
Next Earnings Report
Mar 26, 2026 · After Market Close
Today
EPS Est: $-0.07
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
 Strong Buy 39 77% $1,330.33 +45.2%
JNJ
Johnson & Johnson
 Buy 32 59% $299.55 +24.8%
MRK
Merck & Co. Inc.
 Buy 36 67% $159.27 +33.4%
PFE
Pfizer Inc.
 Hold 35 40% $33.90 +24.3%
BMY
Bristol-Myers Squibb Co
 Hold 36 42% $174.50 +196.1%
ZTS
Zoetis Inc
 Buy 25 64% $209.87 +79.8%
RPRX
Royalty Pharma Plc- Cl A
 Strong Buy 16 88% $36.26 -22.9%
VTRS
Viatris Inc
 Buy 18 67% $122.82 +809.8%